Actually FYI, a meeting with the FDA for CLBP was requested from 1st July, whereas OTAT meeting for sr-GVHD was scheduled last month (according to SI). We don't know when we will hear from OTAT's minutes, but it doesn't seem to follow the 30days time frame. Knowing it's mesoblast, I wouldn't be surprised if the sr-GVHD minutes come in Jan and not this month.
secondly, they are for different products and will be assessed separately.
I too, have an entry price around your level. But I believe in the value of regenerative medicine. When the FDA is ready for such medicine, Mesoblast should be the first to get approval. I would compare meso in medicine to Tesla in EV. Before Tesla, everyone thinks EV will never become mainstream because of the oil&gas industry. Sounds familiar?
Actually FYI, a meeting with the FDA for CLBP was requested from...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.025(2.27%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.21 | $1.07 | $18.96M | 16.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 91002 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 30754 | 6 |
View Market Depth
| Last trade - 11.25am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.11 |
Change
0.025 ( 0.65 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.21 | $1.07 | 3211409 | ||
| Last updated 11.45am 02/05/2024 ? | |||||
| MSB (ASX) Chart |